Patents by Inventor Stephen John Felstead

Stephen John Felstead has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New Salt And Medical Use
    Publication number: 20140248252
    Abstract: The present invention is directed to 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. The invention is also directed to the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 4, 2014
    Applicant: PFIZER LIMITED
    Inventors: Zahid Ali, Kenneth John Butcher, Richard Philip Butt, Stephen John Felstead, Sophie Glatt, Ruth Mitchell McKernan, Maninder Panesar
  • Pharmaceutical Compositions and Methods for CCR5 Antagonists
    Publication number: 20100267765
    Abstract: The present invention relates to a CCR5 antagonist compound for elevating high density lipoprotein (HDL) particles in a patient, improving plasma lipid profile in a patient or reducing triglycerides in a patient. The invention also relates to a pharmaceutical composition comprising a CCR5 antagonist compound, an HMG-CoA reductase inhibitor compound and a pharmaceutically acceptable carrier. The invention also relates to a pharmaceutical composition comprising a CCR5 antagonist compound, a cholesteryl ester transfer protein (CETP) inhibitor compound and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: February 8, 2008
    Publication date: October 21, 2010
    Inventors: Stephen John Felstead, Andrew Lee Hopkins, Howard Bernard Mayer, Mary McHale